Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Wellgistics Health (WGRX) Shares Outstanding (2023 - 2025)

Wellgistics Health filings provide 3 years of Shares Outstanding readings, the most recent being $101.3 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 98.43% to $101.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $101.3 million, a 98.43% increase, with the full-year FY2025 number at $101.3 million, up 98.43% from a year prior.
  • Shares Outstanding hit $101.3 million in Q4 2025 for Wellgistics Health, up from $43.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $101.3 million in Q4 2025 to a low of $43.5 million in Q3 2025.
  • Median Shares Outstanding over the past 3 years was $51.1 million (2024), compared with a mean of $56.4 million.
  • Biggest five-year swings in Shares Outstanding: rose 14.17% in 2024 and later surged 98.43% in 2025.
  • Wellgistics Health's Shares Outstanding stood at $44.7 million in 2023, then grew by 14.17% to $51.1 million in 2024, then surged by 98.43% to $101.3 million in 2025.
  • The last three reported values for Shares Outstanding were $101.3 million (Q4 2025), $89.5 million (Q3 2025), and $63.1 million (Q2 2025) per Business Quant data.